Effects of Midazolam on Brain Injury After Transient Focal Cerebral Ischemia in Rats
Effects of Midazolam on Brain Injury After Transient Focal Cerebral Ischemia in Rats
复制标题
DOI:
10.1097/ana.0b013e318191697a
复制
发表时间:
2009-04-01
影响因子:
3.7
通讯作者:
Kass, Ira S.
中科院分区:
文献类型:
--
作者:
Lei, Baiping;Popp, Susanna;Kass, Ira S.
The benzodiazepine, midazolam, is commonly used for sedation and anesthesia in the operating, room and the intensive care unit where there is a risk of cerebral ischemia. We therefore examined its ability to reduce damage subsequent to cerebral ischemia. Male Wistar rats were randomly assigned to a high-dose midazolam group or a matched vehicle group and a lower dose of midazolam group or a matched vehicle group. The rats underwent 90 minutes of middle cerebral artery occlusion. In the midazolam groups, the first dose of midazolam (10 or 25 mg/kg) was given by 10-minute intravenous infusion before ischemia; a second dose of 1/2 the initial dose (5 or 12.5 mg/kg) was given 1 hour after the onset of ischemia. In the vehicle groups, a similar volume of vehicle was given at the same time intervals. Infarct size. NeuN immunopositive cells in the ischemic penumbral and core regions, and neurologic outcome were determined 7 days after ischemia. Compared with vehicle-treated rats, the higher-dose midazolam (25 mg/kg)-treated rats had a smaller infarct size (93.9 +/- 63.5 mm(3) vs. 152.0 +/- 53.7 mm(3). P < 0.05), more NeUN immunopositive cells in the ischemic core region (206.7 +/- 211.3/mm(2) vs. 40.0 +/- 66.3/mm(2). P < 0.01), and better neurologic outcome (P